Novartis and Medicines for Malaria Venture announce positive efficacy and safety data for a novel treatment for babies <5 kg with malaria

There is currently no evidence-based treatment for the smallest babies with malaria The CALINA study tested a new ratio and dose of Coartem® to account for metabolic differences in babies under 5...

Related Keywords

United States ,Switzerland ,Mali ,Nigeria ,Kenya ,Kigali ,W09 ,Rwanda ,Zambia ,Burkina Faso ,America ,Parag Mahanti ,Sloan Simpson ,Michael Meo ,Jonathan Graham ,Nicole Zinsli Somm ,Isabella Zinck ,Richard Jarvis ,Satoshi Sugimoto ,Marlena Abdinoor ,Imke Kappes ,European Developing Countries Clinical Trials Partnership ,Multilateral Initiative On Malaria ,Exchange Commission ,Linkedin ,Novartis ,Facebook ,Instagram ,Malaria Venture ,Multilateral Initiative ,Pan African Malaria Conference ,Chief Medical Officer ,Developing Countries Clinical Trials Partnership ,Coartem About ,New Artemether Lumefantrine Dispersible Tablet ,Neonates Plasmodium ,Markets ,